NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers Class A common stock of Snowflake Inc. (NYSE: SNOW) between June 27, 2023 and the close of the market on February 28, 2024 (4:00 p.m. ET), inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 27, 2026. SO WHAT: If you purchased Snowflake Class ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Richtech To Contact Him Directly To Discuss Their Options If you purchased or acquiring securities in Richtech between January 27, 2026 and 12:00 PM ET on January 29, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Feb. 26, 2026 (GLOBE ...

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against agilon health, inc. due to alleged violations of federal securities laws, with a deadline for investors to seek lead plaintiff status in a class action lawsuit by March 2, 2026 [4][6]. Group 1: Allegations Against Agilon Health - The complaint alleges that agilon health and its executives made false and misleading statements regarding the company's financial guidance for 2025, which they knew was unattainable due to industry challenges [6]. - It is claimed that the company overstated the financial benefits from strategic actions taken to mitigate risks, leading to materially false representations about its business and prospects [6]. - Following the release of disappointing second-quarter results on August 4, 2025, agilon health's stock plummeted by 51.5% the next day, reflecting the market's reaction to the disclosed information [7]. Group 2: Legal Proceedings and Investor Actions - Investors who purchased agilon health securities between February 26, 2025, and August 4, 2025, are encouraged to contact Faruqi & Faruqi to discuss their legal rights and options [1][9]. - The role of lead plaintiff in the class action is designated to the investor with the largest financial interest, who will oversee the litigation on behalf of the class [8]. - The firm is also seeking information from whistleblowers, former employees, and shareholders regarding agilon health's conduct to support the investigation [9].

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Beyond Meat To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Beyond Meat between February 27, 2025 and November 11, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE ...

Core Viewpoint - ClaimsFiler informs investors about the deadline of April 24, 2026, to file lead plaintiff applications in a securities class action lawsuit against Navan, Inc. related to its October 2025 IPO [1] Group 1: Lawsuit Details - Navan and certain executives are accused of failing to disclose material information during the Class Period, violating federal securities laws [3] - The lawsuit claims that Navan increased its "sales and marketing" expenses for the quarter ending October 31, 2025, to nearly $95 million, a 39% increase from $68.5 million in the quarter ending July 31, 2025 [3] - Following the revelation of true details, Navan's shares reportedly fell sharply [3] Group 2: Legal Assistance - Investors can visit ClaimsFiler's website or call a toll-free number for assistance regarding their legal options [2] - ClaimsFiler provides a platform for retail investors to recover funds from securities class action settlements [5]

Core Viewpoint - ClaimsFiler is reminding investors of the deadline to file lead plaintiff applications in a securities class action lawsuit against Corcept Therapeutics, related to undisclosed material information during the Class Period [1][3]. Group 1: Lawsuit Details - The lawsuit alleges that Corcept and its executives failed to disclose material information, violating federal securities laws during the Class Period from October 31, 2024, to December 30, 2025 [3]. - The complaint specifically mentions that Corcept misled investors regarding the likelihood of FDA approval for its product candidate, relacorilant, following its New Drug Application submission [4]. - Following the disclosure of a Complete Response Letter from the FDA on December 31, 2025, which indicated that additional evidence of effectiveness was needed, Corcept's share price fell by $35.40, or 50.4%, from $70.20 to $34.80 [4]. Group 2: Legal and Investor Support - The case is officially titled Allegheny County Employees' Retirement System v. Corcept Therapeutics Incorporated, No. 26-cv-01525 [5]. - ClaimsFiler provides resources for investors to recover funds from securities class action settlements, including free registration for information access and case evaluations [6].

Core Viewpoint - Enphase Energy, Inc. is facing a securities class action lawsuit for allegedly failing to disclose material information during the class period from April 22, 2025, to October 28, 2025, which may have misled investors [1][3]. Group 1: Lawsuit Details - The lawsuit is pending in the United States District Court for the Northern District of California [1]. - The case is identified as Tripathi v. Enphase Energy, Inc., No. 26-cv-01380 [4]. - Allegations include that Enphase overstated its ability to manage channel inventory and offset impacts from the termination of the Residential Clean Energy Credit, leading to an overstatement of its financial and operational prospects [4]. Group 2: Investor Information - Investors have until April 20, 2026, to file lead plaintiff applications if they purchased Enphase securities during the specified class period [1]. - ClaimsFiler provides resources for investors to recover funds from securities class action settlements, including free registration for access to information and case evaluations [5].

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Smart Digital To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Smart Digital between May 5, 2025 and September 26, 2025 at 9:34 AM EST and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading na ...

SAN FRANCISCO, Feb. 25, 2026 (GLOBE NEWSWIRE) -- National shareholder rights law firm Hagens Berman is notifying investors in Varonis Systems, Inc. (NASDAQ: VRNS) regarding the approaching March 9, 2026, lead plaintiff deadline in a pending securities class action lawsuit that has been filed against the company and certain of its executives. As alleged in the suit, the firm is examining whether Varonis executives concealed significant renewal softness within its Federal vertical and legacy on-premises busin ...

NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the Class A common stock of Snowflake Inc. (“Snowflake” or the “Company”) (NYSE: SNOW) between June 27, 2023 and the close of market on February 28, 2024 (4:00 p.m. EST), inclusive. What To Do Next: For more information, submit a form at Snowflake Inc. Shareholder Class Action Lawsuit, email Investor Relatio ...